AstraZeneca: Antibody cocktail helps prevent COVID-19 for 6 months

eAwaz Medicine

London (reuters) AstraZeneca cemented its lead in bringing a preventative COVID-19 shot to market, saying its antibody cocktail offered 83% protection over six months, providing another possible weapon in the fight against the pandemic. The therapy, called AZD7442 or Evusheld, had previously been shown to confer 77% protection against symptomatic illness after three months, in an earlier readout of the late-stage PROVENT trial in August. The data give hope of additional protection for people who do not respond well to vaccines, such as cancer patients.